Five VC Firms Repeatedly Flex Financial Muscles in Biopharma

Over the first five months of 2021, billions of dollars have been invested in the biopharma industry to support the development of innovative therapies for multiple disease indications. Some of the supporting financiers crop up time and again in financing announcements as they spread the wealth to multiple companies in different stages of drug development.

BioSpace looks at five of the top investor companies that support life sciences companies across the industry.